KRISTIN BAKER: Open Payments
NPI 1992345813 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 24 payments from 12 companies in 2025. Trend: 2023 $1,787 · 2024 $490 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $158 |
| Averitas Pharma Inc. | 2 | $147 |
| Novo Nordisk Inc | 4 | $77 |
| Lilly USA, LLC | 4 | $70 |
| Exact Sciences Corporation | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Organon LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Biogen, Inc. | 1 | $17 |
Products named: QUTENZA, QULIPTA, MOUNJARO, Wegovy, Cologuard Collection Kit, NURTEC ODT, Ozempic, REXULTI.
Industry payments across MO — which companies pay providers there.
